SETD2 and neoplasm: The H3K36me3 methyltransferase SETD2 is generally proposed to function as a tumor suppressor, and loss-of-function mutations in SETD2 occur in a broad spectrum of human malignancies (Duns et al., 2010; Husmann and Gozani, 2019).